340B’s Next Chapter Will Be Won (or Lost) on Data. Most Organizations Aren’t Ready. – The Health Care Blog
By ADAM COHEN The debate over the 340B Drug Pricing Program is complicated. However, beyond the arguments over rebates, contract pharmacies, and program intent sits a simpler reality that every…